VREOF · OTC · CIK 0001771706

Vireo Growth Inc.

Vireo Growth Inc.’s most recent SEC filing in our snapshot is a Form 425 filed on Oct 22, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $268.8M and net income of -$68.1M, according to its XBRL data on EDGAR. Its EDGAR record lists 10 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$268.8M
Net income, FY2025
-$68.1M
Form 4 filings on record, past 12 months
10

Company overview

Legal name (as filed)
Vireo Growth Inc.
Ticker
VREOF
SEC Central Index Key (CIK)
0001771706
Industry (SIC)
Pharmaceutical Preparations (code 2834)
Business address
MINNEAPOLIS, MN
State or country of incorporation
British Columbia, Canada
Fiscal year ends
December 31
SEC filer category
<br>Emerging growth company
Position in SEC ticker list
#2986 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Vireo Growth Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$54.4MFY2021$74.6MFY2022$88.1MFY2023$99.4MFY2024$268.8MFY2025
Net income
-$33.7MFY2021-$42.5MFY2022-$25.5MFY2023-$28.0MFY2024-$68.1MFY2025
VREOF annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$54.4M$74.6M$88.1M$99.4M$268.8M
Net income-$33.7M-$42.5M-$25.5M-$28.0M-$68.1M
Diluted EPS-$0.27-$0.33-$0.19-$0.16-$0.09
Total assets$167.0M$159.2M$183.3M$278.9M$817.2M
Cash and equivalents$15.2M$15.1M$16.0M$91.6M$122.5M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

VREOF latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 17, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 14, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 8, 20268-KMaterial agreement; Agreement terminated; New financial obligation; Regulation FD disclosure· period Oct 2, 2026Document · Index
Apr 16, 2026DEF 14ADefinitive proxy statement· period May 29, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Vireo Growth Inc., by form type:

8-K ×15425 ×14D ×58-K/A ×23 ×14 ×1S-4 ×110-Q ×1
VREOF recent filings
FiledFormWhat it isOriginal
Oct 22, 2026425425Document · Index
Oct 9, 2026S-4Registration statement for business combinationsDocument · Index
Oct 8, 20268-KMaterial agreement; Agreement terminated; New financial obligation; Regulation FD disclosure· period Oct 2, 2026Document · Index
Oct 7, 2026DDDocument · Index
Oct 2, 2026DDDocument · Index
Aug 28, 2026425425Document · Index
Aug 26, 20268-KAcquisition or disposition completed; Unregistered equity sale; Regulation FD disclosure· period Aug 21, 2026Document · Index
Aug 26, 2026425425Document · Index
Aug 25, 2026425425Document · Index
Aug 24, 2026DDDocument · Index
Aug 18, 2026425425Document · Index
Aug 18, 20268-KRegulation FD disclosure; Other events· period Aug 13, 2026Document · Index
Aug 18, 2026425425Document · Index
Aug 14, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 13, 2026425425Document · Index
Aug 13, 2026425425Document · Index
Aug 13, 20268-KMaterial agreement; Acquisition or disposition completed; New financial obligation; Unregistered equity sale; Regulation FD disclosure· period Aug 7, 2026Document · Index
Aug 12, 2026425425Document · Index
Aug 11, 2026425425Document · Index
Aug 11, 2026425425Document · Index
Aug 11, 2026425425Document · Index
Aug 11, 20268-KResults of operations· period Aug 11, 2026Document · Index
Aug 5, 20268-KMaterial agreement; Regulation FD disclosure; Other events· period Jul 30, 2026Document · Index
Jul 30, 2026425425Document · Index
Jul 30, 20268-KMaterial agreement· period Jul 26, 2026Document · Index
Jul 27, 2026425425Document · Index
Jul 27, 20268-KOther events· period Jul 26, 2026Document · Index
Jul 23, 20268-KMaterial agreement; Regulation FD disclosure· period Jul 19, 2026Document · Index
Jun 29, 2026DDDocument · Index
Jun 22, 2026DDDocument · Index
Jun 18, 20268-K/ACurrent report· period Apr 8, 2026Document · Index
Jun 18, 20268-KMaterial agreement; Regulation FD disclosure· period Jun 14, 2026Document · Index
Jun 11, 20268-K/ACurrent report· period Mar 31, 2026Document · Index
Jun 11, 20268-KMaterial agreement; New financial obligation; Unregistered equity sale; Regulation FD disclosure· period Jun 5, 2026Document · Index
Jun 11, 20268-KRegulation FD disclosure; Other events· period Jun 5, 2026Document · Index
Jun 9, 20268-KAuditor change; Regulation FD disclosure· period Jun 5, 2026Document · Index
Jun 8, 20263Initial statement of beneficial ownership· period May 29, 2026Document · Index
Jun 3, 20268-KShareholder vote results· period May 29, 2026Document · Index
May 29, 20268-KMaterial agreement; New financial obligation; Regulation FD disclosure· period May 26, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index

Insider filing activity

10 Form 4 filings appear in Vireo Growth Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Pharmaceutical Preparations

All 194 companies in Pharmaceutical Preparations· Companies headquartered in Minnesota

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001771706 and XBRL company facts. Vireo Growth Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.